ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

INNV vs AHCO // EV/EBITDA & P/E VALUATION

InnovAge Holding Corp. (NASDAQ) VS. AdaptHealth Corp. (NASDAQ) • 15-METRIC TALLY: INNV 5 — AHCO 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INNV VS. AHCO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC INNV AHCO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 18.00% 18.80% -0.80 AHCO /gross-margins <GO>
Return on Invested Capital (ROIC) -10.20% 2.20% -12.40 AHCO /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 6.1x — TIE /valuation <GO>
Free Cash Flow Yield 2.11% — — TIE /fcf-yield <GO>
Operating Margin -3.50% 2.80% -6.30 AHCO /operating-margins <GO>
Net Profit Margin -3.60% -2.20% -1.40 AHCO /net-margins <GO>
Revenue Growth (YoY) 11.80% -0.50% +12.30 INNV /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 4.47 0.79 +3.68 INNV /balance-sheet <GO>
Piotroski F-Score Quality 6/9 4/9 +2.00 INNV /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.7 44.2 +1.49 INNV /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.26B $808.5M $452.3M INNV /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR INNV REV AHCO REV INNV GROSS % AHCO GROSS % INNV FCF AHCO FCF
FY 2025 $853.7M $3.24B 18.0% 18.8% $26.6M $219.4M
FY 2024 $763.9M $3.26B 17.3% 20.9% -$44.8M $235.8M
FY 2023 $688.1M $3.20B — — $20.2M $480.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INNV // BETA —
AHCO // BETA —